Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Sep 14, 2026
- Accession no.
- 0001106578-26-000140
- Filed
- Sep 14, 2026, 4:43 PM ET
- Trade date
- Sep 11, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.76M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $117.76 | +$1,118,720 | 333,943 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −1,341 | $496.74 | −$666,125.52 | 332,602 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −2,138 | $497.99 | −$1,064,700.27 | 330,464 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −1,021 | $498.97 | −$509,445.61 | 329,443 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −204 | $499.61 | −$101,921.44 | 329,239 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −476 | $500.86 | −$238,408.6 | 328,763 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −1,560 | $502.13 | −$783,323.11 | 327,203 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −850 | $503.10 | −$427,633.81 | 326,353 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −710 | $503.99 | −$357,834.89 | 325,643 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −82 | $504.97 | −$41,407.36 | 325,561 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −518 | $506.44 | −$262,336.33 | 325,043 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −320 | $507.31 | −$162,337.63 | 324,723 | Indirect | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −280 | $508.21 | −$142,298.8 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 451,910 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.